ClinConnect ClinConnect Logo
Search / Trial NCT05288985

Impact of Loco-regional Analgesia Following Placement of Erector Spinae Plane Catheter in Addition to Systemic Analgesia in Patients With Thoracic Trauma

Launched by CENTRE HOSPITALIER DEPARTEMENTAL VENDEE · Mar 11, 2022

Trial Information

Current as of November 11, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is investigating a new method of pain management for patients with severe chest injuries, specifically those who have broken more than two ribs on one side. The study aims to see if using a technique called erector spinae plane catheter placement, combined with standard pain relief medication, can help reduce pain and prevent breathing problems better than the usual epidural method, which can be complicated and has some risks.

To participate in this study, patients need to be at least 18 years old, have a specific kind of chest trauma, and be able to communicate their pain levels. They should also be admitted to intensive care but not require a breathing machine. If eligible, participants can expect to receive the new pain management technique and be monitored closely for its effects. The goal is to improve recovery and minimize complications related to breathing after a chest injury.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 years
  • Unibilateral chest trauma with fracture \> 2 ribs on one side
  • Admission to Intensive Care Medicine
  • Non-intubated patient, able to respond to a pain scale score and perform a vital capacity
  • Numerical Scale \> 3 on forced inspiration despite use of systemic analgesics
  • CV ≤ 80% theoretical at inclusion
  • Time \< 24 hours from admission to the service to inclusion
  • Time \< 48h between trauma and inclusion
  • Patient affiliated to the social security system or entitled to it
  • Patient able to understand the protocol, having agreed to participate in the study and having given express oral consent
  • Exclusion Criteria:
  • Intubated, ventilated patient
  • Indication for laparotomy or thoracotomy
  • Spinal cord injury
  • Severe head injury
  • Bilateral thoracic trauma
  • Patient included in a category 1 clinical interventional study involving analgesic treatment
  • Patients under legal protection or deprived of liberty
  • Pregnant or breastfeeding women, or women with childbearing potential without effective contraception
  • Refusal to participate
  • Unable to understand the protocol and its requirements and/or unable to give express oral consent

About Centre Hospitalier Departemental Vendee

The Centre Hospitalier Départemental Vendée is a prominent healthcare institution dedicated to advancing medical knowledge through rigorous clinical research. With a commitment to patient-centered care and innovative treatment approaches, the center actively sponsors clinical trials across various therapeutic areas. By collaborating with multidisciplinary teams of healthcare professionals, the institution aims to enhance clinical outcomes and contribute to the overall improvement of public health. Its strategic focus on ethical research and adherence to regulatory standards ensures that all studies are conducted with the highest level of integrity and scientific rigor.

Locations

La Roche Sur Yon, France

Patients applied

0 patients applied

Trial Officials

Laureen GUILLEMIN

Principal Investigator

Centre Hospitalier Départemental Vendée

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials